Human papilloma virus (HPV) infection is a sexually transmitted infection. Two-dose regimen for HPV vaccine is endorsed by the American Cancer Society, reveals study.
Highlights
- Human Papillomavirus (HPV) is the most common sexually transmitted infections in the United States.
- Two dose-regimen of HPV vaccine recommended by the Advisory Committee on Immunization Practices (ACIP) is endorsed by the American Cancer Society.
- HPV vaccine provides adequate protection for both boys and girls between the age of 9-14 years.
HPV Vaccine is Safe, And Protects Women Across a Broad Age Range
The HPV vaccine protects women against HPV infections during the follow-up period and also protects from many types of HPV across a broad age range.
The HPV vaccine protects women against HPV infections during the follow-up period and also protects from many types of HPV across a broad age range.
‘The American Cancer Society has endorsed the two-dose regimen for Human Papillomavirus (HPV) vaccine.’
Reviewing Data from Clinical Trials The American Cancer Society has reviewed data from several clinical trials and found that two dose regimen of HPV vaccine in boys and girls around the age of 9-14 were found to be protected.
The updated recommendations from ACIP include:
- Two doses of HPV vaccine for persons initiating vaccines before the 15th birthday.
- The second dose of vaccine is initiated after 6-12 months of the first dose.
- A three-dose series vaccine for full HPV protection is given between the age of 15-26 years.
Reasons of Patients for Not Completing HPV Vaccine Series
HPV, the most common sexually transmitted infection, is diagnosed in approximately 14 million people each year in U.S. and can lead to various cancers.
HPV, the most common sexually transmitted infection, is diagnosed in approximately 14 million people each year in U.S. and can lead to various cancers.
Inspite of the safety and efficacy of HPV vaccines, the US vaccination rate is very low when compared to other countries.
Advertisement
New HPV Vaccine, Gardasil 9 by Merck, is More Effective
A new vaccine against sexually transmitted human papillomavirus (HPV), Gardasil 9 made by Merck, is more effective than the previous version.
A new vaccine against sexually transmitted human papillomavirus (HPV), Gardasil 9 made by Merck, is more effective than the previous version.
HPV infection is also linked to vaginal, vulvar, oropharyngeal, anal, and penile cancers apart from cervical cancer.
Advertisement
HPV Vaccine Uptake is Highest Among Girls in High Poverty, Hispanic Communities
Adolescent girls living in high-poverty communities and majority Hispanic communities were more likely to have received at least one dose of HPV vaccine.
Adolescent girls living in high-poverty communities and majority Hispanic communities were more likely to have received at least one dose of HPV vaccine.
- Human Papillomavirus infections are the most common sexually transmitted infections in the United States.
- Around 14 million HPV infections occur every year.
- Cervical cancer is one of the most common types of cancer caused by HPV.
- 4 out of 5 people have HPV infections at any point in their lives.
- HPV vaccine provides protection against 70% of cervical cancers.
- HPV vaccines do not cause fertility problems which are linked to cervical cancers.
- Myths and facts about HPV and the vaccine - (http://www.hpvvaccine.org.au/parents/myths-and-facts-about-hpv-and-the-vaccine.aspx)
- HPV Vaccine: Facts and Fears - (https://www.cancer.org/cancer/cancer-causes/infectious-agents/hpv/hpv-vaccine-facts-and-fears.html)
- Human Papillomavirus (HPV) Vaccines - (https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet#q1)
Source-Medindia
